Javelin Pharmaceuticals, Inc
(AMEX:JAV)|
0.49 -0.06 (-10.91%) Dec 04 - Close |
|
|
|
After-Hours 0.55 +0.06 (12.24%) Thu, 4 Dec 2008 7:40 PM
- Compare JAV with:
- View: Line | Candlestick
Company Profile
Javelin Pharmaceuticals, Inc
125 CambridgePark Drive
Cambridge, MA 02140
United States - Map
Phone: (617) 349-4500
Fax: (617) 349-4505
Website: www.javelinpharmaceuticals.com
State of incorporation: Delaware
CEO: Martin J. Driscoll
Employees: 40
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Major
Pharmaceutical Preparation Manufacturing
A development stage company, which is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.
Recent news for JAV
-
NASDAQ OMX and Leerink Swann to Co-Host HealthCare Industry Forum
GlobeNewswire - 12 hours ago
-
JAVELIN PHARMACEUTICALS, INC Financials
EDGAR Online Financials - Nov 29 at 9:04 ET
-
Javelin Pharmaceuticals Announces 15 Percent Reduction in Workforce
Business Wire - Nov 14 at 10:05 ET
-
Briefing.com - Nov 14 at 10:05 ET
-
New Star Analyst Rankings for JAVELIN PHARMACEUTIC
StarMine - Nov 11 at 9:24 ET
-
Javelin Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 10 at 12:28 ET
-
JAVELIN PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online - Nov 10 at 9:22 ET
-
Javelin Pharmaceuticals, Inc. Reports Third Quarter 2008 Results and Corporate Highlights
Business Wire - Nov 10 at 7:28 ET
-
Q3 2008 JAVELIN PHARMACEUTICALS INC Earnings Release - Time Not Supplied
CCBN - Nov 10 at 7:07 ET
-
Javelin Pharmaceuticals to Review Third Quarter 2008 Financial Results
Business Wire - Nov 06 at 7:40 ET
Top members owning JAV
-
-65.21%3m:
-74.40%YTD:
-
-70.37%3m:
-70.37%YTD:
-
-36.10%3m:
-36.10%YTD: